Trinity Biotech Past Earnings Performance
Past criteria checks 0/6
Trinity Biotech's earnings have been declining at an average annual rate of -10.5%, while the Medical Equipment industry saw earnings growing at 0.5% annually. Revenues have been declining at an average rate of 7.3% per year.
Key information
-10.5%
Earnings growth rate
7.6%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | -7.3% |
| Return on equity | n/a |
| Net Margin | -64.9% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Trinity Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 57 | -37 | 31 | 4 |
| 30 Sep 23 | 71 | -39 | 36 | 4 |
| 30 Jun 23 | 72 | -42 | 34 | 4 |
| 31 Mar 23 | 74 | -34 | 32 | 4 |
| 31 Dec 22 | 63 | -44 | 27 | 4 |
| 30 Sep 22 | 76 | -32 | 25 | 4 |
| 30 Jun 22 | 79 | -22 | 25 | 4 |
| 31 Mar 22 | 86 | -13 | 24 | 4 |
| 31 Dec 21 | 81 | -2 | 23 | 4 |
| 30 Sep 21 | 106 | -8 | 26 | 5 |
| 30 Jun 21 | 116 | -2 | 27 | 5 |
| 31 Mar 21 | 106 | -2 | 25 | 5 |
| 31 Dec 20 | 102 | -6 | 25 | 5 |
| 30 Sep 20 | 91 | -20 | 30 | 5 |
| 30 Jun 20 | 83 | -27 | 31 | 5 |
| 31 Mar 20 | 90 | -31 | 27 | 5 |
| 31 Dec 19 | 90 | -29 | 33 | 5 |
| 30 Sep 19 | 94 | -30 | 28 | 5 |
| 30 Jun 19 | 93 | -29 | 28 | 5 |
| 31 Mar 19 | 95 | -23 | 29 | 5 |
| 31 Dec 18 | 97 | -23 | 29 | 5 |
| 30 Sep 18 | 97 | -39 | 30 | 6 |
| 30 Jun 18 | 99 | -40 | 31 | 6 |
| 31 Mar 18 | 99 | -40 | 31 | 6 |
| 31 Dec 17 | 99 | -39 | 31 | 6 |
| 30 Sep 17 | 98 | -36 | 30 | 5 |
| 30 Jun 17 | 99 | -37 | 30 | 5 |
| 31 Mar 17 | 100 | -36 | 30 | 5 |
| 31 Dec 16 | 100 | -39 | 30 | 5 |
| 30 Sep 16 | 101 | 3 | 29 | 5 |
| 30 Jun 16 | 101 | 16 | 30 | 5 |
| 31 Mar 16 | 98 | 16 | 28 | 5 |
| 31 Dec 15 | 100 | 22 | 28 | 5 |
| 30 Sep 15 | 101 | 23 | 31 | 5 |
| 30 Jun 15 | 103 | 15 | 31 | 4 |
| 31 Mar 15 | 105 | 17 | 30 | 4 |
| 31 Dec 14 | 105 | 15 | 30 | 4 |
| 30 Sep 14 | 103 | 18 | 30 | 4 |
| 30 Jun 14 | 100 | 10 | 29 | 4 |
| 31 Mar 14 | 95 | 10 | 28 | 4 |
| 31 Dec 13 | 91 | 10 | 27 | 4 |
| 30 Sep 13 | 86 | 9 | 23 | 3 |
| 30 Jun 13 | 83 | 17 | 22 | 3 |
Quality Earnings: TRB is currently unprofitable.
Growing Profit Margin: TRB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TRB is unprofitable, and losses have increased over the past 5 years at a rate of 10.5% per year.
Accelerating Growth: Unable to compare TRB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TRB is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-6.1%).
Return on Equity
High ROE: TRB's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.